The Power of Multiplexed Testing
An ongoing clinical study, employing FlashDx? RP1.1 test kits at a children's hospital in China has unveiled a multifaceted trend in respiratory disease-related pathogens. These kits, based upon FlashDx’s semi-Solid Phase Real-Time (SPRT) PCR technologies, are capable of detecting 10 common respiratory pathogens in a single test within an hour.
The study found that the human parainfluenza virus (PIV) and respiratory syncytial virus (RSV) were the most frequently detected pathogens in the summer (https://www.dhirubhai.net/pulse/low-season-all-year-round-preparedness-flashdx-inc). Researchers are also tracking in real time the prevalence of these respiratory pathogens, observing a recent surge in rhinovirus/enterovirus and RSV cases, while SARS-CoV-2 remains a relatively small proportion of the positive cases.
The study underscores the clinical utilities of the FlashDx? RP1.1 test kits in identifying multiple pathogens in a single analysis, enabling physicians to provide more precise diagnoses and targeted treatments. These tests not only expedite the diagnostic process, typically delivering results within 2 hours of sample collection, but also help conserve resources for hospitals and clinics, ultimately leading to improved patient outcomes.
FlashDx? RP1.1 tests include:
Molecular Diagnostic R&D Leader
1 年Interesting findings! Great to see FlashDx's multiplexed test in clinical application.